TPG to Buy Envision Pharmaceutical
Envision Pharmaceutical Holdings said Monday it has agreed to be sold to TPG. Company management and other Envision senior executives will take a significant minority stake in the company. Financial terms weren't announced. Envision is a pharmaceutical benefits manager. J.P. Morgan served as financial advisor to Envision while Bank of America Merrill Lynch and Credit Suisse were financial advisors to TPG. J.P. Morgan, Bank of America Merrill Lynch and Credit Suisse are providing financing to TPG.
8 July 2013•4 mins read
